A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in BMC Microbiology
- Vol. 9 (1), 113
- https://doi.org/10.1186/1471-2180-9-113
Abstract
Staphylococcus aureus is a major human pathogen, especially methicillin-resistant S. aureus (MRSA), which causes a wide range of hospital and community-acquired infections worldwide. Conventional testing for detection of MRSA takes 2–5 days to yield complete information of the organism and its antibiotic sensitivity pattern. The present study focused on the development of a pentaplex PCR assay for the rapid detection of MRSA. The assay simultaneously detected five genes, namely 16S rRNA of the Staphylococcus genus, femA of S. aureus, mecA that encodes methicillin resistance, lukS that encodes production of Panton-Valentine leukocidin (PVL), a necrotizing cytotoxin, and one internal control. Specific primer pairs were successfully designed and simultaneously amplified the targeted genes. The analytical sensitivity and specificity of the pentaplex PCR assay was evaluated by comparing it with the conventional method. The analytical sensitivity of the pentaplex PCR at the DNA level was found to be 10 ng DNA. The analytical specificity was evaluated with 34 reference staphylococci and non-staphylococcal strains and was found to be 100%. The diagnostic evaluation of MRSA carried out using 230 clinical isolates, showed 97.6% of sensitivity, 99.3% of specificity, 98.8% of positive predictive value and 98.6% of negative predictive value compared to the conventional method. The presence of an internal control in the pentaplex PCR assay is important to exclude false-negative cases. The pentaplex PCR assay developed was rapid and gave results within 4 h, which is essential for the identification of Staphylococcus spp., virulence and their resistance to methicillin. Our PCR assay may be used as an effective surveillance tool to survey the prevalence of MRSA and PVL-producing strains in hospitals and the community.Keywords
This publication has 33 references indexed in Scilit:
- Community-acquired methicillin-resistant Staphylococcus aureus: current perspectivesClinical Microbiology & Infection, 2006
- Results of Disk Diffusion Testing with Cefoxitin Correlate with Presence of mecA in Staphylococcus sppJournal of Clinical Microbiology, 2005
- New Quadriplex PCR Assay for Detection of Methicillin and Mupirocin Resistance and Simultaneous Discrimination ofStaphylococcus aureusfrom Coagulase-Negative StaphylococciJournal of Clinical Microbiology, 2004
- Methicillin-resistantStaphylococcus aureusin Europe, 1999–2002Emerging Infectious Diseases, 2004
- Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide EmergenceEmerging Infectious Diseases, 2003
- Pathogenesis of infections due to coagulasenegative staphylococciThe Lancet Infectious Diseases, 2002
- Multiplex PCR for Simultaneous Identification of Staphylococcus aureus and Detection of Methicillin and Mupirocin ResistanceJournal of Clinical Microbiology, 2001
- Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections.2001
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Coagulase-negative staphylococci: Pathogens with increasing clinical significanceThe Journal of Pediatrics, 1990